Ken Greenberg
Partner @ Venrock Healthcare Capital Partners
New City, United States
Ken Greenberg is a Series B investor at Venrock Healthcare Capital Partners in New City focused on Medical and Biotechnology. Ken Greenberg
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Ken Greenberg invests in
Stages Ken Greenberg invests in
Countries Ken Greenberg invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (100%)
- Biotechnology 2 (100%)
- Health Care 1 (50%)
- Therapeutics 1 (50%)
Stage
- Series B 1 (50%)
- Series D 1 (50%)
Country
- United States 1 (50%)
- United Kingdom 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CellCentric
|
CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer. | $220M / Series D / May 06, 2026 | |
AIRNA
|
AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals suffering from both rare and common ailments. | $155M / Series B / Apr 01, 2025 |
Co-Investors
Venrock Healthcare Capital Partners is a fund dedicated to investing in publicly-held and privately-held healthcare companies. It leverages its venture expertise, rigorous data analysis, and long-term supportive orientation to support successful biotechnology companies within the public markets. The company is headquartered in Palo Alto,California with an office in New York, New York.
Venrock Healthcare Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Ken Greenberg
Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ken Greenberg invest in?
Ken Greenberg invests primarily in Medical, Biotechnology and Health Care startups, most often at Series B and Series D stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ken Greenberg?
Public channels for Ken Greenberg include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ken Greenberg last invest?
The most recent investment recorded for Ken Greenberg closed in May 2026. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
